Brawn Biotech opened at ₹22.00, in line with its previous close of ₹22.00. In the last trading session on 12 Nov 2026, the stock traded between ₹22.00 and ₹22.00, with an average traded price of ₹22.00. It showed a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Brawn Biotech is now worth
₹ 11,000.00
Giving a profit of
₹ 1,000.00 (10.00%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.00 (+0.00%)
Day High
₹22.00
Day Low
₹22.00
Day Open
₹22.00
Prev Close
₹22.00
Volume
60
Value Traded
₹0.00 Cr
1W Return
-5.01%
1M Return
-13.78%
3M Return
4.76%
6M Return
7.32%
1Y Return
9.67%
Market Cap (₹ Cr.)
7
PE Ratio
8.10
PB Ratio
1.46
Dividend Yield
-
ROE
21.68%
ROCE
0.10%
Book Value (₹)
15.11
Face Value (₹)
10.00
EPS (TTM)
-0.08
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-5.01%
6 Weeks
-
1 Month
-13.78%
3 Months
4.76%
9 Months
18.28%
No data available.
Brawn Biotech Q2FY27 Results: Net profit falls 58% YoY to ₹3 lakh
Net profit fell 57.6% YoY to ₹3.03 lakh in Q2FY27. Revenue from operations rose 15% YoY to ₹562.45 lakh. Total expenses increased 16.8% YoY, outpacing revenue growth. Cash and cash equivalents declined to ₹18.73 lakh from ₹28.06 lakh. Current trade receivables surged to ₹706.71 lakh from ₹354.77 lakh.
6 days agoBrawn Biotech submits undertaking for non-applicability of RPT disclosures
Brawn Biotech Ltd filed an undertaking with BSE for non-applicability of RPT disclosures for FY26. Paid-up share capital stood at ₹3 crore, well below the ₹10 crore threshold. Net worth was approximately ₹4.32 crore, under the ₹25 crore limit. Company cited Regulation 15(2) of SEBI LODR Regulations, 2015 for the exemption. Metrics remained below specified thresholds for the last three consecutive financial years.
7 days agoBrawn Biotech appoints GDSM and Co. as statutory auditors till FY31
Appointed M/s. GDSM and Co. as statutory auditors effective September 29, 2026. Auditor tenure extends through FY31 (Financial Year 2030-31). Reappointed Brij Raj Gupta as Director following retirement by rotation. Gupta holds 500,774 equity shares as on March 31, 2026.
1mo agoBrawn Biotech passes all resolutions at 41st AGM; promoters back re-appointment
All four ordinary resolutions passed at Brawn Biotech's 41st AGM held on September 29, 2026. Promoter group voted 100% in favour across all items, casting 10,00,574 votes each. Public shareholders supported financial statement adoption with 97.84% votes in favour. Managerial remuneration approval saw lower public support at 94.58% compared to other items.
1mo agoBrawn Biotech FY26 revenue up 26% to ₹169.8 crore; net loss narrows
Revenue grew 26.1% YoY to ₹169.78 crore in FY26. Net loss narrowed 45.9% to ₹94.1 lakh, driven by tax adjustments. 41st AGM scheduled for September 29, 2026, via VC/OAVM. Remote e-voting opens September 26 and closes September 28.
2mo agoBrawn Biotech net profit falls 35% in Q1FY26 to ₹15.44 lakh
Brawn Biotech's Q1FY26 net profit fell 35% to ₹15.44 lakh despite a 5.6% rise in operating income to ₹621.74 lakh. The decline was attributed to a sharp increase in expenses, particularly inventory changes. The board approved the results and recommended new statutory auditors.
3mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,896.40 | +0.60% | ₹4,55,009.88 | 41.20 | +9.49% | |
| ₹11,503.00 | +0.16% | ₹3,05,368.51 | 90.40 | +76.43% | |
| ₹4,686.00 | -0.87% | ₹1,78,240.38 | 85.50 | +22.52% | |
| ₹2,432.80 | +1.37% | ₹1,31,447.16 | 97.10 | +145.92% | |
| ₹1,204.50 | -0.12% | ₹1,20,149.34 | 28.00 | +26.60% | |
| ₹1,388.50 | +0.14% | ₹1,15,895.36 | 42.00 | +12.92% | |
| ₹1,408.80 | +0.04% | ₹1,13,811.10 | 39.90 | -7.27% | |
| ₹2,665.50 | +1.02% | ₹1,10,097.17 | 48.10 | +17.42% | |
| ₹1,814.80 | +0.42% | ₹1,04,419.58 | 26.00 | +53.33% | |
| ₹2,019.00 | +0.20% | ₹92,326.85 | 17.60 | -0.73% | |
| ₹2,641.50 | -0.69% | ₹74,549.65 | 51.60 | +42.95% | |
| ₹5,182.50 | -2.25% | ₹61,964.56 | 30.50 | -10.14% |
An investment of ₹10,000 made 5 years ago in Brawn Biotech is now worth
₹ 11,000.00
Giving a profit of
₹ 1,000.00 (10.00%)
Note: Past profits do not guarantee future returns.
